Govt Should Buy Up Domestic Antibiotic APIs, Cost 5-8 Times Higher: Industry Official

Masaya Tamae, Executive Officer, Meiji Seika Pharma, Project Leader, FPMAJ, at Healthcare Industry Platform Symposium on April 22 If Japan begins manufacturing APIs for four key antibiotics that the nation currently relies heavily on from overseas suppliers, the government should...read more